Efficacy Testing Market

Efficacy Testing Market by Service Type (Antimicrobial/Preservative Efficacy Testing, Disinfectant Efficacy Testing (Surface, Suspension)), Application (Pharmaceutical Manufacturing, Cosmetic & Personal Care Products, Consumer) - Global Forecast to 2025

Report Code: BT 5932 Sep, 2020, by marketsandmarkets.com

[142 Pages Report] The global efficacy testing market is projected to reach USD 333 million by 2025 from USD 261 million in 2020, at a CAGR of 5.0% during the forecast period. The growth of this market is mainly driven by the increasing use of surface disinfectants and preservatives in pharma, biopharma, and cosmetics industries for contamination control and product stability; growing preference for outsourcing efficacy testing; and the rising adoption of the QbD approach.

Efficacy Testing Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact On The Global Efficacy Testing Market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a matter of a few weeks. The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020.

The COVID-19 outbreak has made institutional and household disinfection increasingly important to prevent the spread of the disease. Many consumers have responded by panic-buying disinfecting products to ensure that they can keep their homes virus-free. As a result, synthetic disinfectants are running out of stock at retail stores. In response, retailers are dealing with the spike in demand by restocking their shelves with green disinfectants. The EPA is also adding many natural disinfectants to its "approved" list for fighting COVID-19.

Post COVID-19, the demand for surface disinfectants is expected to scale up due to the threat of the reemergence of the virus. Considering these factors, the COVID-19 pandemic is expected to result in the emergence of new domestic players in the surface disinfectants market, which in turn, will boost the demand for disinfectant efficacy testing.

The COVID-19 pandemic has had a major impact on China, the US, and European countries. As these countries are the major producers of drugs, medical devices, and cosmetics products, the pandemic has caused a slowdown in manufacturing and product development processes. This has negatively affected the preservative efficacy testing market. However, the market is expected to recover in the next 1 to 2 years

Efficacy Testing Market Dynamics

Driver: Growing preference for outsourcing efficacy testing

Pharmaceutical, cosmetic, and medical device companies opt to outsource numerous core functions like manufacturing, clinical trial management, and portions of drug discovery to CROs, as the emergence of new technologies has made it unfeasible for companies to undertake all testing functions in-house. In the pharmaceutical industry, analytical and testing services were the most-outsourced services, followed by clinical trials, formulation development, solid-dosage form manufacturing, injectable manufacturing, and R&D. This trend is supported by an increase in the numbers, capabilities, and sizes of CROs and the preference for specific providers over the long-term as opposed to short-term contracts—the preferred vendor concept. In the coming years, outsourcing as a strategy is expected to gain greater prominence. The expected rise in pharmaceutical drugs and cosmetics production will bring with it a growing demand for the associated analytical testing services—compatibility studies for biosimilars, stability testing, and product release testing (including antimicrobial effectiveness testing and disinfectant efficacy testing) to reduce the risks associated with product development.

The outsourcing of efficacy testing services helps pharmaceutical companies mitigate risks by avoiding large investments in purchasing analytical equipment and maintaining manpower, especially when development efforts are in the early stages. The availability of specialized efficacy testing service providers with key capabilities to provide optimum results rapidly has led to increasing consideration among pharmaceutical companies to outsource testing services to third-party service providers

Opportunity: Emerging countriesinthe Asia Pacific Region

Emerging markets present significant growth opportunities for providers of healthcare analytical testing services—particularly India and China. Governments in both countries are emphasizing the development of life science infrastructure by undertaking several projects and initiatives to encourage pharmaceutical and biopharmaceutical companies to develop and manufacture drugs for various infectious and chronic diseases.

According to a report from the India Brand Equity Foundation (IBEF), India’s domestic pharmaceutical industry was growing at a rate of 9–10% to reach USD 20.03 billion in 2019 from USD 18.12 billion in 2018. However, with the support of the government and regulatory bodies, the industry can grow at a pace of 11–12%. Government support in the form of regulatory interventions and investments is an integral steptoward the initiation of innovation-led industry growth. Moreover, the favorable government scenario has encouraged start-ups by providing them soft loans for pharma industrial R&D projects and a grant-in-aid for clinical trials for developing drugs for neglected diseases. The government is also providing non-fiscal benefits, such as assistance in research in all systems of medicines (including setting up facilities and joint research projects for industries and institutions).

According to J.P. Morgan estimates, China is a dominant market for skincare products. It accounted for a share of 14% of the global market in 2018, up from 12% in 2013. In 2018, beauty sales in China grew by 12.9%; this figure was 4.6% in the US. The country has quickly gained on the US in beauty sales and is set to overtake it by 2023, even if growth slows down.

The growth in the pharmaceutical and cosmetics industries in these countries is expected to drive the demand for efficacy testing services in the coming years.

Challenges: Time-consuming process

Preservative and disinfectant efficacy testing is a set of procedures involving considerable cost, time, and scientific expertise in order to ensure the quality, efficacy, and safety of a drug formulation. Conventional preservative efficacy tests or preservative challenge test methods generally require microbial assays at multiple test points over extended periods. The duration of the tests typically ranges from a minimum of 28 days to 12 or more weeks. This process is also labor-intensive and requires extensive hands-on testing with no potential for automation.

Preservative efficacy testing involves well-established protocols as set out in the British, US, Japan, and European Pharmacopeias. However, microbiologists face several challenges while optimizing assays, which can result in increased timelines and budgets (ending in results that do not satisfy requirements). In recent years, rapid tests, which use biosensor systems, have been developed. These tests provide results in lesser time as compared to conventional PET tests. However, it is becoming a challenge for service providers to constantly seek newer, more sensitive and less time-consuming assays to cater to the changing demands of end users.

By service type, the disinfectant efficacy testing segment accounted for the largest share of the efficacy testing market in 2019.

Based on the product, the efficacy testing market is segmented into antimicrobial/preservative efficacy testing (AET/PET) and disinfectant efficacy testing. The disinfectant efficacy testing segment dominated this market in 2019. Growing awareness of environmental & personal hygiene has resulted in the increasing production and use of surface disinfectants. This, in turn, is driving the demand for disinfectant efficacy testing.

By application, the pharmaceutical manufacturing applications segment accounted for the largest share of the efficacy testing market in 2019.

Based on application, the efficacy testing market is segmented into pharmaceutical manufacturing applications, cosmetics and personal care product applications, consumer product applications, and medical device applications. The pharmaceutical manufacturing applications segment dominated this market in 2019 and is estimated to grow at the highest CAGR during the forecast period. The growth of this segment is majorly attributed to factors such as the stringent regulations for the microbial testing of pharma drugs for regulatory approval and the growing focus on patient safety.

North America accounted for the largest share of the efficacy testing market in 2019.

In 2019, North America accounted for the largest share of the efficacy testing market. The major factors driving the growth of the North American efficacy testing services market include the presence of a wellestablished pharmaceutical industry in the region, the high R&D expenditure, a strong presence of major service providers, and rising outsourcing of analytical testing (including efficacy testing) by pharmaceutical and cosmetic companies in the region.

Efficacy Testing Market  by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

The global efficacy testing market is dominated by a few globally established players such as Eurofins Scientific (Luxembourg), Charles River Laboratories (US), WuXi AppTech (China), and SGS (Switzerland).

Scope of the Report

Report Metric

Details

Market Size Available for Years

2018–2025

Base Year Considered

2019

Forecast Period

2020–2025

Forecast Units

Value (USD Million)

Segments Covered

Product, Application, and Region

Geographies Covered

North America, Europe, APAC and the RoW

Companies Covered

The major market players include as Eurofins Scientific (Luxembourg), Charles River Laboratories (US), WuXi AppTech (China), SGS (Switzerland), Intertek Group (UK), Almac Group (UK), and Pacific Biolabs (US).
(Total 25 companies)

The study categorizes the efficacy testing market into the following segments and subsegments:

By Service Type

  • Antimicrobial/Preservative Efficacy Testing
    • Traditional Test Method
    • Rapid Test Method
  • Disinfectant Efficacy Testing
    • Surface Test Method
    • Suspension Test Method

By Application

  • Pharmaceutical Manufacturing Applications
  • Cosmetics and Personal Care Product Applications
  • Consumer Product Applications
  • Medical Device Applications

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • The Middle East and Africa

Recent Developments

  • In 2018, Eurofins Scientific acquired PHAST, which helped complement Eurofins’ BioPharma
  • Product Testing portfolio and expanded its geographical footprint.
  • In 2018, WuXi AppTec opened a new medical device testing center in Suzhou, China. The
  • new center will include services such as biomaterials analysis, toxicology, biocompatibility, risk assessment, aseptic product design, microbiology, physical testing of packaging and shelf life, and product batch-release testing.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 21)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 25)
    2.1 RESEARCH APPROACH
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    2.1.2.1 Breakdown of primary sources
                               FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
                    2.1.2.2 Key industry insights
    2.2 MARKET SIZE ESTIMATION
           FIGURE 2 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
           FIGURE 3 EFFICACY TESTING MARKET: FINAL CAGR PROJECTIONS (2020−2025)
           FIGURE 4 EFFICACY TESTING MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS, CHALLENGES, AND OPPORTUNITIES
           FIGURE 5 EFFICACY TESTING MARKET: SEGMENTAL ASSESSMENT
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 6 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET RANKING ANALYSIS
    2.5 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY (Page No. - 33)
    FIGURE 7 EFFICACY TESTING MARKET, BY SERVICE TYPE, 2020 VS. 2025 (USD MILLION)
    FIGURE 8 EFFICACY TESTING MARKET, BY APPLICATION, 2020–2025
    FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE EFFICACY TESTING MARKET

4 PREMIUM INSIGHTS (Page No. - 36)
    4.1 EFFICACY TESTING MARKET OVERVIEW
           FIGURE 10 GROWING PREFERENCE FOR OUTSOURCING EFFICACY TESTING TO DRIVE MARKET GROWTH
    4.2 ASIA PACIFIC: EFFICACY TESTING MARKET,  BY APPLICATION & COUNTRY (2019)
           FIGURE 11 PHARMACEUTICAL MANUFACTURING APPLICATIONS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2019
    4.3 DISINFECTANT EFFICACY TESTING MARKET, BY METHOD
           FIGURE 12 SURFACE TEST METHOD SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 38)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 13 EFFICACY TESTING MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing use of surface disinfectants and preservatives in pharma, biopharma, and cosmetics industries for contamination control and product stability
                               5.2.1.1.1 Rising focus on contamination control
                               5.2.1.1.2 Increasing concerns over product stability
                    5.2.1.2 Growing preference for outsourcing efficacy testing
                    5.2.1.3 Rising adoption of the Quality by Design approach
           5.2.2 OPPORTUNITIES
                    5.2.2.1 Emerging countries in the Asia Pacific region
           5.2.3 CHALLENGES
                    5.2.3.1 Time-consuming process
    5.3 REGULATORY ANALYSIS
           5.3.1 DISINFECTANT EFFICACY TESTING
           5.3.2 ANTIMICROBIAL EFFICACY TESTING
    5.4 IMPACT OF COVID-19 ON EFFICACY TESTING SERVICES

6 EFFICACY TESTING MARKET, BY SERVICE TYPE (Page No. - 44)
    6.1 INTRODUCTION
           TABLE 1 EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
    6.2 DISINFECTANT EFFICACY TESTING
           6.2.1 RISING USE OF SURFACE DISINFECTANTS IN MANUFACTURING FACILITIES FOR CONTAMINATION CONTROL TO BOOST MARKET GROWTH
                    TABLE 2 DISINFECTANT EFFICACY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
                    TABLE 3 NORTH AMERICA: DISINFECTANT EFFICACY TESTING MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
                    TABLE 4 EUROPE: DISINFECTANT EFFICACY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 5 APAC: DISINFECTANT EFFICACY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 6 ROW: DISINFECTANT EFFICACY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
                    TABLE 7 DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
           6.2.2 SURFACE TEST METHOD
                    TABLE 8 SURFACE TEST METHOD MARKET, BY REGION, 2018–2025 (USD MILLION)
                    TABLE 9 NORTH AMERICA: SURFACE TEST METHOD MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 10 EUROPE: SURFACE TEST METHOD MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 11 APAC: SURFACE TEST METHOD MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           6.2.3 SUSPENSION TEST METHOD
                    TABLE 12 SUSPENSION TEST METHOD MARKET, BY REGION, 2018–2025 (USD MILLION)
                    TABLE 13 NORTH AMERICA: SUSPENSION TEST METHOD MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
                    TABLE 14 EUROPE: SUSPENSION TEST METHOD MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 15 APAC: SUSPENSION TEST METHOD MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    6.3 ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING
           6.3.1 AET/PET TESTING ENSURES PRODUCTS HAVE MET THE REQUIRED QUALITY, SAFETY, AND PERFORMANCE STANDARDS
                    TABLE 16 EUROFINS SCIENTIFIC AET TEST PROTOCOL
                    TABLE 17 ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY REGION,  2018–2025 (USD MILLION)
                    TABLE 18 NORTH AMERICA: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET,  BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 19 EUROPE: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 20 APAC: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
                    TABLE 21 ROW: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY REGION,  2018–2025 (USD MILLION)
                    TABLE 22 ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD,  2018–2025 (USD MILLION)
           6.3.2 TRADITIONAL TEST METHOD
                    TABLE 23 TRADITIONAL TEST METHOD MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.3 RAPID TEST METHOD
                    TABLE 24 RAPID TEST METHOD MARKET, BY REGION, 2018–2025 (USD MILLION)

7 EFFICACY TESTING MARKET, BY APPLICATION (Page No. - 54)
    7.1 INTRODUCTION
           TABLE 25 EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
    7.2 PHARMACEUTICAL MANUFACTURING APPLICATIONS
           7.2.1 INCREASING FOCUS ON ENSURING THE QUALITY OF DRUGS TO DRIVE MARKET GROWTH
                    TABLE 26 EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS,  BY REGION, 2018–2025 (USD MILLION)
                    TABLE 27 NORTH AMERICA: EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 28 EUROPE: EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 29 APAC: EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
    7.3 COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS
           7.3.1 EFFICACY TESTING IS AN ESSENTIAL PART OF THE STABILITY TESTING REGIMEN OF COSMETICS
                    TABLE 30 EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
                    TABLE 31 NORTH AMERICA: EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 32 EUROPE: EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 33 APAC: EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
    7.4 CONSUMER PRODUCT APPLICATIONS
           7.4.1 GROWING FOCUS ON A HEALTHY ENVIRONMENT IN HOMES AND INDUSTRIAL FACILITIES TO DRIVE MARKET GROWTH
                    TABLE 34 EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
                    TABLE 35 NORTH AMERICA: EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 36 EUROPE: EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS,  BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 37 APAC: EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS,  BY COUNTRY, 2018–2025 (USD MILLION)
    7.5 MEDICAL DEVICE APPLICATIONS
           7.5.1 IMPOSITION OF RIGOROUS GOVERNMENT REGULATIONS IS A MAJOR FACTOR DRIVING MARKET GROWTH
                    TABLE 38 EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS, BY REGION,  2018–2025 (USD MILLION)
                    TABLE 39 NORTH AMERICA: EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS,  BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 40 EUROPE: EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
                    TABLE 41 APAC: EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)

8 EFFICACY TESTING MARKET, BY REGION (Page No. - 63)
    8.1 INTRODUCTION
           TABLE 42 EFFICACY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
    8.2 NORTH AMERICA
           FIGURE 14 NORTH AMERICA: EFFICACY TESTING MARKET SNAPSHOT
           TABLE 43 NORTH AMERICA: EFFICACY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 44 NORTH AMERICA: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
           TABLE 45 NORTH AMERICA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,  2018–2025 (USD MILLION)
           TABLE 46 NORTH AMERICA: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET,  BY METHOD, 2018–2025 (USD MILLION)
           TABLE 47 NORTH AMERICA: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           8.2.1 US
                    8.2.1.1 The US dominated the North American efficacy testing market in 2019
                               TABLE 48 US: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
                               TABLE 49 US: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
                               TABLE 50 US: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           8.2.2 CANADA
                    8.2.2.1 Government initiatives to drive market growth in Canada
                               TABLE 51 CANADA: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
                               TABLE 52 CANADA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
                               TABLE 53 CANADA: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
    8.3 EUROPE
           TABLE 54 EUROPE: EFFICACY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 55 EUROPE: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
           TABLE 56 EUROPE: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
           TABLE 57 EUROPE: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
           TABLE 58 EUROPE: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           8.3.1 GERMANY
                    8.3.1.1 Germany is the largest market for efficacy testing services in Europe
                               TABLE 59 GERMANY: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
                               TABLE 60 GERMANY: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
                               TABLE 61 GERMANY: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           8.3.2 FRANCE
                    8.3.2.1 High demand for cosmetic products in France will drive growth in the efficacy testing market for cosmetic product applications
                               TABLE 62 FRANCE: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
                               TABLE 63 FRANCE: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
                               TABLE 64 FRANCE: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           8.3.3 UK
                    8.3.3.1 Efficacy testing market in the UK is primarily driven by the enforcement of regulatory and industry standards
                               TABLE 65 UK: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
                               TABLE 66 UK: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
                               TABLE 67 UK: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           8.3.4 ITALY
                    8.3.4.1 Increasing pharmaceutical production in Italy will drive the demand for efficacy testing for pharmaceutical applications
                               TABLE 68 ITALY: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
                               TABLE 69 ITALY: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
                               TABLE 70 ITALY: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           8.3.5 SPAIN
                    8.3.5.1 Rising R&D expenditure to boost the growth of the Spanish market
                               TABLE 71 SPAIN: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
                               TABLE 72 SPAIN: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
                               TABLE 73 SPAIN: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           8.3.6 REST OF EUROPE
                    TABLE 74 ROE: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
                    TABLE 75 ROE: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
                    TABLE 76 ROE: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
    8.4 APAC
           FIGURE 15 APAC: EFFICACY TESTING MARKET SNAPSHOT
           TABLE 77 APAC: EFFICACY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 78 APAC: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
           TABLE 79 APAC: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
           TABLE 80 APAC: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD,  2018–2025 (USD MILLION)
           TABLE 81 APAC: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           8.4.1 CHINA
                    8.4.1.1 China is the largest market for efficacy testing services in the Asia Pacific
                               TABLE 82 CHINA: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
                               TABLE 83 CHINA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,  2018–2025 (USD MILLION)
                               TABLE 84 CHINA: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           8.4.2 JAPAN
                    8.4.2.1 Rising R&D investments to drive market growth in Japan
                               TABLE 85 JAPAN: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
                               TABLE 86 JAPAN: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
                               TABLE 87 JAPAN: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           8.4.3 INDIA
                    8.4.3.1 Growing pharmaceutical industry in India to drive market growth
                               TABLE 88 INDIA: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
                               TABLE 89 INDIA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
                               TABLE 90 INDIA: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           8.4.4 REST OF APAC
                    TABLE 91 ROAPAC: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
                    TABLE 92 ROAPAC: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
                    TABLE 93 ROAPAC: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
    8.5 REST OF THE WORLD
           TABLE 94 ROW: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
           TABLE 95 ROW: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION)
           TABLE 96 ROW: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD,  2018–2025 (USD MILLION)
           TABLE 97 ROW: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 98 ROW: EFFICACY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION)
           8.5.1 LATIN AMERICA
                    TABLE 99 LATAM: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
                    TABLE 100 LATAM: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           8.5.2 MIDDLE EAST AND AFRICA
                    TABLE 101 MEA: EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION)
                    TABLE 102 MEA: EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)

9 COMPETITIVE LANDSCAPE (Page No. - 89)
    9.1 COMPANY EVALUATION MATRIX
           9.1.1 STARS
           9.1.2 EMERGING LEADERS
           9.1.3 PERVASIVE
           9.1.4 EMERGING COMPANIES
                    FIGURE 16 EFFICACY TESTING MARKET: COMPANY EVALUATION MATRIX (2019)
    9.2 MARKET RANKING ANALYSIS
           FIGURE 17 MARKET RANKING IN THE EFFICACY TESTING MARKET (2019)
    9.3 EFFICACY TESTING MARKET: GEOGRAPHIC ASSESSMENT
           FIGURE 18 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE EFFICACY TESTING MARKET (2019)

10 COMPANY PROFILES (Page No. - 92)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     10.1 EFFICACY TESTING SERVICE PROVIDERS
             10.1.1 EUROFINS SCIENTIFIC
                       FIGURE 19 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
             10.1.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
                       FIGURE 20 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2019)
             10.1.3 WUXI APPTEC
                       FIGURE 21 WUXI APPTEC: COMPANY SNAPSHOT (2019)
             10.1.4 SGS SA
                       FIGURE 22 SGS SA: COMPANY SNAPSHOT (2019)
             10.1.5 INTERTEK GROUP PLC
                       FIGURE 23 INTERTEK GROUP: COMPANY SNAPSHOT (2019)
             10.1.6 MICROCHEM LABORATORY
             10.1.7 ACCUGEN LABORATORIES, INC.
             10.1.8 PACIFIC BIOLABS
             10.1.9 NORTH AMERICAN SCIENCE ASSOCIATES
             10.1.10 TOXIKON
             10.1.11 BIOSCIENCE LABORATORIES, INC.
             10.1.12 CONSUMER PRODUCT TESTING COMPANY (CPTC)
             10.1.13 ALMAC GROUP
             10.1.14 MSL SOLUTION PROVIDERS
             10.1.15 NELSON LABORATORIES, LLC (A SOTERA HEALTH COMPANY)
             10.1.16 ALS LIMITED
             10.1.17 ABBOTT ANALYTICAL
             10.1.18 BLUTEST LABORATORIES LIMITED
             10.1.19 LUCIDEON
             10.1.20 HELVIC LABORATORIES (A TENTAMUS COMPANY)
     10.2 MANUFACTURERS OF DISINFECTANTS
             10.2.1 PROCTER & GAMBLE
                       FIGURE 24 PROCTER & GAMBLE: COMPANY SNAPSHOT (2019)
             10.2.2 THE CLOROX COMPANY
                       FIGURE 25 THE CLOROX COMPANY: COMPANY SNAPSHOT (2019)
             10.2.3 3M GROUP
                       FIGURE 26 3M GROUP: COMPANY SNAPSHOT (2019)
             10.2.4 RECKITT BENCKISER GROUP PLC
                       FIGURE 27 RECKITT BENCKISER GROUP PLC: COMPANY SNAPSHOT (2019)
             10.2.5 STERIS PLC
                       FIGURE 28 STERIS PLC: COMPANY SNAPSHOT (2019)
             10.2.6 ECOLAB INC.
                       FIGURE 29 ECOLAB INC.: COMPANY SNAPSHOT (2019)
             10.2.7 CANTEL MEDICAL CORPORATION
                       FIGURE 30 CANTEL MEDICAL CORPORATION: COMPANY SNAPSHOT (2019)
             10.2.8 DIVERSEY, INC.
             10.2.9 MEDLINE INDUSTRIES, INC.
             10.2.10 BETCO

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

11 APPENDIX (Page No. - 136)
     11.1 DISCUSSION GUIDE
     11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     11.3 AVAILABLE CUSTOMIZATIONS
     11.4 RELATED REPORTS
     11.5 AUTHOR DETAILS

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global efficacy testing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the efficacy testing market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Data

This research study involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies’ house documents, investor presentations, and SEC filings of companies. The secondary sources referred to for this research study include publications from government sources, such as the European Federation of Pharmaceutical Industries and Association, European Trade Association, Environmental Protection Agency, International Journal of Environmental Research and Public Health, Pharmaceutical Research and Manufacturers of America, United States Pharmacopeia, European Pharmacopoeia, World Health Organization, and US Food and Drug Administration. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the efficacy testing market. It was also used to obtain important information about the key players and market classification, segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Data

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report.

Primary sources from the supply side include CEOs, vice presidents, marketing and sales directors, business development managers, technology and innovation directors of companies providing efficacy testing services, key opinion leaders, and suppliers. Primary sources from the demand side include scientists, researchers, microbiologists, and other related key executives from pharmaceutical and biotechnology companies.

Primary research was used in this report to:

  • Validate the market segmentation defined through service portfolio assessment of leading players in the efficacy testing market
  • Understand key industry trends and issues defining the strategic growth objectives of market players
  • Gather both demand- and supply-side validation of key factors affecting the market growth (such as market drivers, challenges, and opportunities)
  • Validate assumptions for the market sizing and forecasting model used for this study
  • Understand the market position of leading players in the efficacy testing market and their market share/ranking

Efficacy Testing Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the efficacy testing market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the efficacy testing market

Report Objectives

  • To define, describe, and forecast the efficacy testing market by service type, application, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, the Asia Pacific (APAC), and the Rest of the World (RoW) 2
  • To profile the key players and comprehensively analyze their service portfolios, market positions, and core competencies3
  • To track and analyze competitive developments such as acquisitions and expansions in the efficacy testing market

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the efficacy testing market into specific countries for the LATAM and MEA regions.

Company Information

Detailed analysis and profiling of additional market players (up to 3) inclusive of:

  • Business Overview
  • Financial Information
  • Services Offered
  • Developments (Last three years)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Efficacy Testing Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Efficacy Testing Market

Request For Special Pricing
Report Code
BT 5932
Published ON
Sep, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Efficacy Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home